FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Claus Hellerbrand

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Mouse
Rats

Anatomy

Procedures

Reverse Transcriptase Polymerase Chain Reaction

Physiology

Phenomena

Blotting, Western

Co-author Network

Publications

TOP 3
Katharina Limm; Daniel W Mueller; Peter Oefner; Corinna Ott; Susanne Wallner; Claus Hellerbrand; Anja-Katrin Bosserhoff
Deregulation of protein methylation in melanoma.
Yan Liu; Christoph Meyer; Peter ten Dijke; Honglei Weng; Chengfu Xu; Claus Hellerbrand; Steven Dooley
Animal models of chronic liver diseases.
P Dietrich; Claus Hellerbrand; F Kees; L Moleda; M Müller; R H Straub; Reiner Wiest
Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Claus Hellerbrand (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Katharina Limm; Daniel W Mueller; Peter Oefner; Corinna Ott; Susanne Wallner; Claus Hellerbrand; Anja-Katrin Bosserhoff
Deregulation of protein methylation in melanoma.
European journal of cancer (Oxford, England : 1990) 2013;49(6):1305-13.
2013: Yan Liu; Christoph Meyer; Peter ten Dijke; Honglei Weng; Chengfu Xu; Claus Hellerbrand; Steven Dooley
Animal models of chronic liver diseases.
American journal of physiology. Gastrointestinal and liver physiology 2013;304(5):G449-68.
2013: P Dietrich; Claus Hellerbrand; F Kees; L Moleda; M Müller; R H Straub; Reiner Wiest
Dysbalance in sympathetic neurotransmitter release and action in cirrhotic rats: impact of exogenous neuropeptide Y.
Journal of hepatology 2013;58(2):254-61.
2013: Christoph Dorn; Jörg Heilmann; Sabine Massinger; Andreas Wuzik; Claus Hellerbrand
Xanthohumol suppresses inflammatory response to warm ischemia-reperfusion induced liver injury.
Experimental and molecular pathology 2013;94(1):10-6.
2012: Christopher Soll; Peter J Wild; Michelle L DeOliveira; Claus Hellerbrand; Christian Eugen Oberkofler; Marc-Oliver Riener; Pierre-Alain Clavien
Expression of serotonin receptors in human hepatocellular cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2012;18(21):5902-10.
2012: Michael Saugspier; Barbara Czech; Christoph Dorn; Manfred Gehrig; Jörg Heilmann; Claus Hellerbrand
Hop bitter acids inhibit tumorigenicity of hepatocellular carcinoma cells in vitro.
Oncology reports 2012;28(4):1423-8.
2012: Daniela Valletta; Anja-Katrin Bosserhoff; Barbara Czech; Martina Müller; Wolfgang E Thasler; Claus Hellerbrand
Expression and function of the atypical cadherin FAT1 in chronic liver disease.
Biochemical and biophysical research communications 2012;426(3):404-8.
2012: Anja Thomas; Axel P Stevens; Katja Dettmer; Wolfram Gronwald; Claus Hellerbrand; Matthias S Klein; Peter J Oefner; Jörg Reinders
Early changes in the liver-soluble proteome from mice fed a nonalcoholic steatohepatitis inducing diet.
Proteomics 2012;12(9):1437-51.
2012: Michael Saugspier; Wolfgang E Thasler; Christoph Dorn; Manfred Gehrig; Jörg Heilmann; Claus Hellerbrand
Hop bitter acids exhibit anti-fibrogenic effects on hepatic stellate cells in vitro.
Experimental and molecular pathology 2012;92(2):222-8.
2012: Monika Ridinger; Gerd Schmitz; Norbert Wodarz; Erwin Gäbele; Paul Kiefer; Philiph Köhl; Claus Hellerbrand
Analysis of carbohydrate deficient transferrin serum levels during abstinence.
Experimental and molecular pathology 2012;92(1):50-3.
2012: Jennifer Schmidt; Thilo Spruss; Raphael Stoll; Thomas Amann; Florian Fink; Wolfram Gronwald; Claus Hellerbrand; Burkhard König; Alexander Riechers; Anja Katrin Bosserhoff
Targeting melanoma metastasis and immunosuppression with a new mode of melanoma inhibitory activity (MIA) protein inhibition.
PloS one 2012;7(5):e37941.
2012: Christoph Roderburg; Frank Tacke; Christian Trautwein; David Vargas Cardenas; Mihael Vucur; Henning Zimmermann; Katharina Berger; Brenda Bongaerts; Natalia Elfimova; Claus Hellerbrand; Alexander Koch; Mark Luedde; Tobias Mollnow; Margarete Odenthal; Tom Luedde
Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosis.
PloS one 2012;7(3):e32999.
2012: Christoph Dorn; Jörg Heilmann; Claus Hellerbrand
Protective effect of xanthohumol on toxin-induced liver inflammation and fibrosis.
International journal of clinical and experimental pathology 2012;5(1):29-36.
2011: Roland Walter; Josef Wanninger; Thomas S Weiss; Thomas Amann; Sabrina Bauer; Kristina Eisinger; Claus Hellerbrand; Markus Neumeier; Andreas Schäffler; Jürgen Schölmerich; Christa Buechler
Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitis.
Experimental and molecular pathology 2011;91(3):740-4.
2011: Georgi Kirovski; Lukas Moleda; Catrin Niessen; Doris Schacherer; Reiner Wiest; Hella Wobser; Christa Buechler; Christoph Dorn; Hanna Huber; Claus Hellerbrand
Elevated systemic monocyte chemoattractrant protein-1 in hepatic steatosis without significant hepatic inflammation.
Experimental and molecular pathology 2011;91(3):780-3.
2011: Bernd Schnabl; Daniela Valletta; Georgi Kirovski; Claus Hellerbrand
Zinc finger protein 267 is up-regulated in hepatocellular carcinoma and promotes tumor cell proliferation and migration.
Experimental and molecular pathology 2011;91(3):695-701.
2011: Sabrina Bauer; Stefan Farkas; Claus Hellerbrand; Mirko Ritter; Doris Schacherer; Andreas Schäffler; Marcus N Scherer; Gerd Schmitz; Thomas S Weiss; Reiner Wiest; Christa Buechler
Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro.
Experimental and molecular pathology 2011;91(3):733-9.
2011: Erwin Gäbele; Claus Hellerbrand; Claudia Hofmann; Jürgen Schölmerich; Reiner Wiest; Karin Dostert; Florian Obermeier
DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH.
Journal of hepatology 2011;55(6):1391-9.
2011: Johannes Taeger; Edward K Geissler; Gabriel Glockzin; Claus Hellerbrand; Christian Moser; Maria E Mycielska; Hans J Schlitt; Oliver Stoeltzing; Sven A Lang
Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer.
Molecular cancer therapeutics 2011;10(11):2157-67.
2011: Ulrike Maegdefrau; Stephanie Arndt; Claus Hellerbrand; Georgi Kivorski; Anja-Katrin Bosserhoff
Downregulation of hemojuvelin prevents inhibitory effects of bone morphogenetic proteins on iron metabolism in hepatocellular carcinoma.
Laboratory investigation; a journal of technical methods and pathology 2011;91(11):1615-23.
2011: Josef Wanninger; Thomas S Weiss; Sabrina Bauer; Christoph Dorn; Kristina Eisinger; Claus Hellerbrand; Andreas Schäffler; Roland Walter; Christa Buechler
MMP-9 activity is increased by adiponectin in primary human hepatocytes but even negatively correlates with serum adiponectin in a rodent model of non-alcoholic steatohepatitis.
Experimental and molecular pathology 2011;91(2):603-7.
2011: Josef Wanninger; Thomas S Weiss; Charalampos Aslanidis; Sabrina Bauer; Claus Hellerbrand; Hanna Huber; Markus Neumeier; Doris Schacherer; Andreas Schäffler; Jürgen Schölmerich; Christa Buechler
Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytes.
Biochimica et biophysica acta 2011;1811(10):626-33.
2011: Karl Quint; Helmut Sitter; Claudia Steindorf; Abbas Agaimy; Pietro Di Fazio; Arndt Hartmann; Claus Hellerbrand; Rudolf Jung; Roberta Montalbano; Daniel Neureiter; Matthias Ocker
Clinical significance of histone deacetylases 1, 2, 3, and 7: HDAC2 is an independent predictor of survival in HCC.
Virchows Archiv : an international journal of pathology 2011;459(2):129-39.
2011: Gabriele Sass; Hüseyin Sirma; Henning Wege; Said Hashemolhosseini; Claus Hellerbrand; Nina Klinger; Daniel Neureiter; Matthias Ocker; Gisa Tiegs
Inhibition of experimental HCC growth in mice by use of the kinase inhibitor DMAT.
International journal of oncology 2011;39(2):433-42.
2011: Lukas Moleda; Tilman Sauerbruch; Juergen Schoelmerich; Rainer H Straub; Jonel Trebicka; Peter Dietrich; Erwin Gäbele; Claus Hellerbrand; Reiner Wiest
Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
Gut 2011;60(8):1122-32.
2011: Eleonora Patsenker; Hans Saegesser; Vreni Schneider; Christoph Dorn; Claus Hellerbrand; Monika Ledermann; Felix Stickel
Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.
Journal of hepatology 2011;55(2):388-98.
2011: Janin Henkel; Nancy Schanze; Christoph Dorn; Sheila R Elz; Daniela Gärtner; Claus Hellerbrand; Gerhard P Püschel
Oncostatin M produced in Kupffer cells in response to PGE2: possible contributor to hepatic insulin resistance and steatosis.
Laboratory investigation; a journal of technical methods and pathology 2011;91(7):1107-17.
2011: Erwin Gäbele; Christoph Dorn; Karin Dostert; Eleonora Patsenker; Felix Stickel; Claus Hellerbrand
A new model of interactive effects of alcohol and high-fat diet on hepatic fibrosis.
Alcoholism, clinical and experimental research 2011;35(7):1361-7.
2011: Josef Wanninger; Markus Neumeier; Sabrina Bauer; Thomas S Weiss; Kristina Eisinger; Roland Walter; Christoph Dorn; Claus Hellerbrand; Andreas Schäffler; Christa Buechler
Adiponectin induces the transforming growth factor decoy receptor BAMBI in human hepatocytes.
FEBS letters 2011;585(9):1338-44.
2011: Thomas Amann; Georgi Kirovski; Anja Kathrin Bosserhoff; Claus Hellerbrand
Analysis of a promoter polymorphism of the GLUT1 gene in patients with hepatocellular carcinoma.
Molecular membrane biology 2011;28(3):182-6.
2011: Georgi Kirovski; Axel P Stevens; Barbara Czech; Katja Dettmer; Thomas S Weiss; Peter Wild; Arndt Hartmann; Anja K Bosserhoff; Peter J Oefner; Claus Hellerbrand
Down-regulation of methylthioadenosine phosphorylase (MTAP) induces progression of hepatocellular carcinoma via accumulation of 5'-deoxy-5'-methylthioadenosine (MTA).
The American journal of pathology 2011;178(3):1145-52.
2011: Elke Schaeffeler; Heiko van der Kuip; Stefan Winter; Ulrich M Zanger; Claus Hellerbrand; Ute Hofmann; Hermann Koepsell; Stephan Kruck; Anne T Nies; Matthias Schwab
DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma.
Genome medicine 2011;3(12):82.
2011: Bernd Schnabl; Daniela Valletta; Thomas S Weiss; Barbara Czech; Georgi Kirovski; Claus Hellerbrand
Increased expression of zinc finger protein 267 in non-alcoholic fatty liver disease.
International journal of clinical and experimental pathology 2011;4(7):661-6.
2011: Anja Bosserhoff; Claus Hellerbrand
Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.
Digestive diseases (Basel, Switzerland) 2011;29(4):377-83.
2011: Sabrina Bauer; Josef Wanninger; Sandra Schmidhofer; Johanna Weigert; Markus Neumeier; Christoph Dorn; Claus Hellerbrand; Nicole Zimara; Andreas Schäffler; Charalampos Aslanidis; Christa Buechler
Sterol regulatory element-binding protein 2 (SREBP2) activation after excess triglyceride storage induces chemerin in hypertrophic adipocytes.
Endocrinology 2011;152(1):26-35.
2010: Tina Gimm; Melanie Wiese; Barbara Teschemacher; Anke Deggerich; Johannes Schödel; Karl X Knaup; Thomas Hackenbeck; Claus Hellerbrand; Kerstin Amann; Michael S Wiesener; Stefan Höning; Kai-Uwe Eckardt; Christina Warnecke
Hypoxia-inducible protein 2 is a novel lipid droplet protein and a specific target gene of hypoxia-inducible factor-1.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2010;24(11):4443-58.
2010: Roland Buettner; I Bettermann; C Hechtl; Erwin Gäbele; Claus Hellerbrand; Jurgen Schölmerich; L Cornelius Bollheimer
Dietary folic acid activates AMPK and improves insulin resistance and hepatic inflammation in dietary rodent models of the metabolic syndrome.
Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme 2010;42(11):769-74.
2010: Felix Stickel; Claus Hellerbrand
Non-alcoholic fatty liver disease as a risk factor for hepatocellular carcinoma: mechanisms and implications.
Gut 2010;59(10):1303-7.
2010: Friederike Böhm; Tobias Speicher; Claus Hellerbrand; Clive Dickson; Juha M Partanen; David M Ornitz; Sabine Werner
FGF receptors 1 and 2 control chemically induced injury and compound detoxification in regenerating livers of mice.
Gastroenterology 2010;139(4):1385-96.
2010: Andrea Reinartz; Josef Ehling; Andrea Leue; Christian Liedtke; Ursula Schneider; Jürgen Kopitz; Thomas Weiss; Claus Hellerbrand; Ralf Weiskirchen; Ruth Knüchel; Nikolaus Gassler
Lipid-induced up-regulation of human acyl-CoA synthetase 5 promotes hepatocellular apoptosis.
Biochimica et biophysica acta 2010;1801(9):1025-35.
2010: Christoph Dorn; Frauke Bataille; Erwin Gaebele; Jörg Heilmann; Claus Hellerbrand
Xanthohumol feeding does not impair organ function and homoeostasis in mice.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2010;48(7):1890-7.
2010: Christoph Dorn; Birgit Kraus; Magdalena Motyl; Thomas S Weiss; Manfred Gehrig; Jürgen Schölmerich; Jörg Heilmann; Claus Hellerbrand
Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis.
Molecular nutrition & food research 2010;54 Suppl 2():S205-13.
2010: Thomas Amann; Yvonne Egle; Anja Bosserhoff; Claus Hellerbrand
FHL2 suppresses growth and differentiation of the colon cancer cell line HT-29.
Oncology reports 2010;23(6):1669-74.
2010: Axel P Stevens; Katja Dettmer; Georgi Kirovski; Keijiro Samejima; Claus Hellerbrand; Anja Bosserhoff; Peter J Oefner
Quantification of intermediates of the methionine and polyamine metabolism by liquid chromatography-tandem mass spectrometry in cultured tumor cells and liver biopsies.
Journal of chromatography. A 2010;1217(19):3282-8.
2010: Christina Hackl; Akira Mori; Christian Moser; Sven A Lang; Rania Dayoub; Thomas S Weiss; Hans J Schlitt; Edward K Geissler; Claus Hellerbrand; Oliver Stoeltzing
Effect of heat-shock protein-90 (HSP90) inhibition on human hepatocytes and on liver regeneration in experimental models.
Surgery 2010;147(5):704-12.
2010: Lukas Moleda; Lars Jurzik; Matthias Froh; Erwin Gäbele; Claus Hellerbrand; Rainer H Straub; Jürgen Schölmerich; Reiner Wiest
Role of HSP-90 for increased nNOS-mediated vasodilation in mesenteric arteries in portal hypertension.
World journal of gastroenterology : WJG 2010;16(15):1837-44.
2010: Thomas Amann; Frauke Bataille; Thilo Spruss; Katja Dettmer; Peter Wild; Christian Liedtke; Marcus Mühlbauer; Paul Kiefer; Peter J Oefner; Christian Trautwein; Anja Bosserhoff; Claus Hellerbrand
Reduced expression of fibroblast growth factor receptor 2IIIb in hepatocellular carcinoma induces a more aggressive growth.
The American journal of pathology 2010;176(3):1433-42.
2010: Frank Grünhage; Jacob Nattermann; Olav A Gressner; Hermann E Wasmuth; Claus Hellerbrand; Tilman Sauerbruch; Ulrich Spengler; Frank Lammert
Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C.
Journal of hepatology 2010;52(2):153-9.
2010: Christoph Dorn; Thomas S Weiss; Jörg Heilmann; Claus Hellerbrand
Xanthohumol, a prenylated chalcone derived from hops, inhibits proliferation, migration and interleukin-8 expression of hepatocellular carcinoma cells.
International journal of oncology 2010;36(2):435-41.
2010: Katrin Dietl; Kathrin Renner; Katja Dettmer; Birgit Timischl; Karin Eberhart; Christoph Dorn; Claus Hellerbrand; Michael Kastenberger; Leoni A Kunz-Schughart; Peter J Oefner; Reinhard Andreesen; Eva Gottfried; Marina Kreutz
Lactic acid and acidification inhibit TNF secretion and glycolysis of human monocytes.
Journal of immunology (Baltimore, Md. : 1950) 2010;184(3):1200-9.
2010: Claus Hellerbrand
Pathophysiological similarities and synergisms in alcoholic and non-alcoholic steatohepatitis.
Digestive diseases (Basel, Switzerland) 2010;28(6):783-91.
2010: Christina Hackl; Sven A Lang; Christian Moser; Akira Mori; Stefan Fichtner-Feigl; Claus Hellerbrand; Wolfgang Dietmeier; Hans J Schlitt; Edward K Geissler; Oliver Stoeltzing
Activating transcription factor-3 (ATF3) functions as a tumor suppressor in colon cancer and is up-regulated upon heat-shock protein 90 (Hsp90) inhibition.
BMC cancer 2010;10():668.
2010: Georgi Kirovski; Erwin Gäbele; Christoph Dorn; Lukas Moleda; Christoph Niessen; Thomas S Weiss; Hella Wobser; Doris Schacherer; Christa Buechler; Hermann E Wasmuth; Claus Hellerbrand
Hepatic steatosis causes induction of the chemokine RANTES in the absence of significant hepatic inflammation.
International journal of clinical and experimental pathology 2010;3(7):675-80.
2010: Georgi Kirovski; Doris Schacherer; Hella Wobser; Hanna Huber; Christoph Niessen; Catrin Beer; Jürgen Schölmerich; Claus Hellerbrand
Prevalence of ultrasound-diagnosed non-alcoholic fatty liver disease in a hospital cohort and its association with anthropometric, biochemical and sonographic characteristics.
International journal of clinical and experimental medicine 2010;3(3):202-10.
2010: Gabriele Kirchner; Georgi Kirovski; Alexandra Hebestreit; Jürgen Schölmerich; Hans Jürgen Schlitt; Oliver Stoeltzing; Claus Hellerbrand
Epidemiology and survival of patients with hepatocellular carcinoma in Southern Germany.
International journal of clinical and experimental medicine 2010;3(2):169-79.
2010: Christoph Dorn; Marc-Oliver Riener; Georgi Kirovski; Michael Saugspier; Kathrin Steib; Thomas S Weiss; Erwin Gäbele; Glen Kristiansen; Arndt Hartmann; Claus Hellerbrand
Expression of fatty acid synthase in nonalcoholic fatty liver disease.
International journal of clinical and experimental pathology 2010;3(5):505-14.
2010: Henning W Zimmermann; Sebastian Seidler; Jacob Nattermann; Nikolaus Gassler; Claus Hellerbrand; Alma Zernecke; J J W Tischendorf; Tom Luedde; Ralf Weiskirchen; Christian Trautwein; Frank Tacke
Functional contribution of elevated circulating and hepatic non-classical CD14CD16 monocytes to inflammation and human liver fibrosis.
PloS one 2010;5(6):e11049.
2010: Stephanie Arndt; Ulrike Maegdefrau; Christoph Dorn; Katharina Schardt; Claus Hellerbrand; Anja Bosserhoff
Iron-induced expression of bone morphogenic protein 6 in intestinal cells is the main regulator of hepatic hepcidin expression in vivo.
Gastroenterology 2010;138(1):372-82.
2010: Astrid Slany; Verena J Haudek; Hannes Zwickl; Nina C Gundacker; Michael Grusch; Thomas S Weiss; Katja Seir; Chantal Rodgarkia-Dara; Claus Hellerbrand; Christopher Gerner
Cell characterization by proteome profiling applied to primary hepatocytes and hepatocyte cell lines Hep-G2 and Hep-3B.
Journal of proteome research 2010;9(1):6-21.
2009: Thomas Amann; Claus Hellerbrand
GLUT1 as a therapeutic target in hepatocellular carcinoma.
Expert opinion on therapeutic targets 2009;13(12):1411-27.
2009: Erwin Gäbele; Marcus Mühlbauer; Hartwig Paulo; Monika Johann; Christin Meltzer; Franz Leidl; Norbert Wodarz; Reiner Wiest; Jürgen Schölmerich; Claus Hellerbrand
Analysis of monocyte chemotactic protein-1 gene polymorphism in patients with spontaneous bacterial peritonitis.
World journal of gastroenterology : WJG 2009;15(44):5558-62.
2009: Hella Wobser; Christoph Dorn; Thomas S Weiss; Thomas Amann; Cornelius Bollheimer; Roland Büttner; Jürgen Schölmerich; Claus Hellerbrand
Lipid accumulation in hepatocytes induces fibrogenic activation of hepatic stellate cells.
Cell research 2009;19(8):996-1005.
2009: Ulrike Maegdefrau; Thomas Amann; Andreas Winklmeier; Simone Braig; Thomas Schubert; Thomas S Weiss; Katharina Schardt; Christina Warnecke; Claus Hellerbrand; Anja Bosserhoff
Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
The Journal of pathology 2009;218(4):520-9.
2009: Marc-Oliver Riener; Frank Stenner; Heike Liewen; Claus Hellerbrand; Marcus Bahra; Glen Kristiansen
Alpha-fetoprotein and serum golgi phosphoprotein 2 are equally discriminative in detecting early hepatocellular carcinomas.
Hepatology (Baltimore, Md.) 2009;50(1):326.
2009: Hermann E Wasmuth; Frank Lammert; Mirko Moreno Zaldivar; Ralf Weiskirchen; Claus Hellerbrand; David Scholten; Marie-Luise Berres; Henning Zimmermann; Konrad L Streetz; Frank Tacke; Sonja Hillebrandt; Petra Schmitz; Hildegard Keppeler; Thomas Berg; Edgar Dahl; Nikolaus Gassler; Scott L Friedman; Christian Trautwein
Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans.
Gastroenterology 2009;137(1):309-19, 319.e1-3.
2009: Marc-Oliver Riener; Frank Stenner; Heike Liewen; Christopher Soll; Stefan Breitenstein; Bernhard C Pestalozzi; Panagiotis Samaras; Nicole M Probst-Hensch; Claus Hellerbrand; Beat Müllhaupt; Pierre-Alain Clavien; Marcus Bahra; Peter Neuhaus; Peter Wild; Florian Fritzsche; Holger Moch; Wolfram Jochum; Glen Kristiansen
Golgi phosphoprotein 2 (GOLPH2) expression in liver tumors and its value as a serum marker in hepatocellular carcinomas.
Hepatology (Baltimore, Md.) 2009;49(5):1602-9.
2009: Marianne Antoine; Roman Köhl; Carmen G Tag; Axel M Gressner; Claus Hellerbrand; Paul Kiefer
Secreted cysteine-rich FGF receptor derives from posttranslational processing by furin-like prohormone convertases.
Biochemical and biophysical research communications 2009;382(2):359-64.
2009: Thomas Amann; Ulrike Maegdefrau; Arndt Hartmann; Abbas Agaimy; Jörg Marienhagen; Thomas S Weiss; Oliver Stoeltzing; Christina Warnecke; Jürgen Schölmerich; Peter J Oefner; Marina Kreutz; Anja Bosserhoff; Claus Hellerbrand
GLUT1 expression is increased in hepatocellular carcinoma and promotes tumorigenesis.
The American journal of pathology 2009;174(4):1544-52.
2009: Thomas Amann; Frauke Bataille; Thilo Spruss; Marcus Mühlbauer; Erwin Gäbele; Jürgen Schölmerich; Paul Kiefer; Anja Bosserhoff; Claus Hellerbrand
Activated hepatic stellate cells promote tumorigenicity of hepatocellular carcinoma.
Cancer science 2009;100(4):646-53.
2009: Christa Buechler; Andreas Schäffler; Monika Johann; Markus Neumeier; Philip Köhl; Thomas Weiss; Norbert Wodarz; Paul Kiefer; Claus Hellerbrand
Elevated adiponectin serum levels in patients with chronic alcohol abuse rapidly decline during alcohol withdrawal.
Journal of gastroenterology and hepatology 2009;24(4):558-63.
2009: Hermann E Wasmuth; Carmen G Tag; Eddie Van de Leur; Claus Hellerbrand; Tobias Mueller; Thomas Berg; Gero Puhl; Peter Neuhaus; Didier Samuel; Christian Trautwein; Sandip M Kanse; Ralf Weiskirchen
The Marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB.
Hepatology (Baltimore, Md.) 2009;49(3):775-80.
2009: Marianne Antoine; Carmen G Tag; Axel M Gressner; Claus Hellerbrand; Paul Kiefer
Expression of E-selectin ligand-1 (CFR/ESL-1) on hepatic stellate cells: implications for leukocyte extravasation and liver metastasis.
Oncology reports 2009;21(2):357-62.
2009: Sven A Lang; Christian Moser; Stefan Fichnter-Feigl; Philipp Schachtschneider; Claus Hellerbrand; Volker Schmitz; Hans J Schlitt; Edward K Geissler; Oliver Stoeltzing
Targeting heat-shock protein 90 improves efficacy of rapamycin in a model of hepatocellular carcinoma in mice.
Hepatology (Baltimore, Md.) 2009;49(2):523-32.
2009: Marie-Luise Berres; Sven Papen; Katrin Pauels; Petra Schmitz; Mirko Moreno Zaldivar; Claus Hellerbrand; Tobias Mueller; Thomas Berg; Ralf Weiskirchen; Christian Trautwein; Hermann E Wasmuth
A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
Journal of hepatology 2009;50(2):370-6.
2009: Ramin Massoumi; Silke Kuphal; Claus Hellerbrand; Bodo Haas; Peter Wild; Thilo Spruss; Alexander Pfeifer; Reinhard Fässler; Anja Bosserhoff
Down-regulation of CYLD expression by Snail promotes tumor progression in malignant melanoma.
The Journal of experimental medicine 2009;206(1):221-32.
2009: Erwin Gäbele; Matthias Froh; Gavin E Arteel; Takehiko Uesugi; Claus Hellerbrand; Jürgen Schölmerich; David A Brenner; Ronald G Thurman; Richard A Rippe
TNFalpha is required for cholestasis-induced liver fibrosis in the mouse.
Biochemical and biophysical research communications 2009;378(3):348-53.
2008: Tonio Wiederholt; Michael von Westernhagen; Mirko Moreno Zaldivar; Marie-Luise Berres; Petra Schmitz; Claus Hellerbrand; Tobias Müller; Thomas Berg; Christian Trautwein; Hermann E Wasmuth
Genetic variations of the chemokine scavenger receptor D6 are associated with liver inflammation in chronic hepatitis C.
Human immunology 2008;69(12):861-6.
2008: Reiner Wiest; Lukas Moleda; Bettina Zietz; Claus Hellerbrand; Jürgen Schölmerich; Rainer Straub
Uncoupling of sympathetic nervous system and hypothalamic-pituitary-adrenal axis in cirrhosis.
Journal of gastroenterology and hepatology 2008;23(12):1901-8.
2008: Erwin Gäbele; Marcus Mühlbauer; Christoph Dorn; Thomas S Weiss; Matthias Froh; Bernd Schnabl; Reiner Wiest; Jürgen Schölmerich; Florian Obermeier; Claus Hellerbrand
Role of TLR9 in hepatic stellate cells and experimental liver fibrosis.
Biochemical and biophysical research communications 2008;376(2):271-6.
2008: Matthias Froh; Zhi Zhong; Peter Walbrun; Mark Lehnert; Susanne Netter; Reiner Wiest; Lars Conzelmann; Erwin Gabele; Claus Hellerbrand; Jurgen Scholmerich; Ronald-G Thurman
Dietary glycine blunts liver injury after bile duct ligation in rats.
World journal of gastroenterology : WJG 2008;14(39):5996-6003.
2008: Bernd Schnabl; Katharina Brandl; Marina Fink; Philipp Gross; Kojiro Taura; Erwin Gäbele; Claus Hellerbrand; Werner Falk
A TLR4/MD2 fusion protein inhibits LPS-induced pro-inflammatory signaling in hepatic stellate cells.
Biochemical and biophysical research communications 2008;375(2):210-4.
2008: Weihua Xu; Claus Hellerbrand; Ulrike A Köhler; Philippe Bugnon; Yuet Wai Kan; Sabine Werner; Tobias A Beyer
The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis.
Laboratory investigation; a journal of technical methods and pathology 2008;88(10):1068-78.
2008: Felix Stickel; Christoph H Osterreicher; Juliane Halangk; Thomas Berg; Nils Homann; Claus Hellerbrand; Eleonora Patsenker; Vreni Schneider; Armin Kolb; Helmut Friess; Detlef Schuppan; Gero Puhl; Helmut K Seitz; Julian L B Leathart; Christopher P Day
No role of matrixmetalloproteinase-3 genetic promoter polymorphism 1171 as a risk factor for cirrhosis in alcoholic liver disease.
Alcoholism, clinical and experimental research 2008;32(6):959-65.
2008: Christoph H Osterreicher; Juliane Halangk; Thomas Berg; Eleonora Patsenker; Nils Homann; Claus Hellerbrand; Helmut K Seitz; Dennis Eurich; Felix Stickel
Evaluation of the transforming growth factor beta1 codon 25 (Arg-->Pro) polymorphism in alcoholic liver disease.
Cytokine 2008;42(1):18-23.
2008: Hermann E Wasmuth; Mirko Moreno Zaldivar; Marie-Luise Berres; Alexa Werth; David Scholten; Sonja Hillebrandt; Frank Tacke; Petra Schmitz; Edgar Dahl; Tonio Wiederholt; Claus Hellerbrand; Thomas Berg; Ralf Weiskirchen; Christian Trautwein; Frank Lammert
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection.
Journal of hepatology 2008;48(2):208-15.
2008: Claus Hellerbrand; T Amann; J Schlegel; P Wild; Frauke Bataille; Thilo Spruss; A Hartmann; Anja Bosserhoff
The novel gene MIA2 acts as a tumour suppressor in hepatocellular carcinoma.
Gut 2008;57(2):243-51.
2008: Christian Moser; Sven A Lang; Akira Mori; Claus Hellerbrand; Hans J Schlitt; Edward K Geissler; William E Fogler; Oliver Stoeltzing
ENMD-1198, a novel tubulin-binding agent reduces HIF-1alpha and STAT3 activity in human hepatocellular carcinoma(HCC) cells, and inhibits growth and vascularization in vivo.
BMC cancer 2008;8():206.
2007: Frank Tacke; Erwin Gäbele; Frauke Bataille; Robert F Schwabe; Claus Hellerbrand; Frank Klebl; Rainer H Straub; Tom Luedde; Michael P Manns; Christian Trautwein; David A Brenner; Jürgen Schölmerich; Bernd Schnabl
Bone morphogenetic protein 7 is elevated in patients with chronic liver disease and exerts fibrogenic effects on human hepatic stellate cells.
Digestive diseases and sciences 2007;52(12):3404-15.
2007: Claus Hellerbrand; Hermann E Wasmuth
Genomewide genetic association studies in hepatology: the end of searching for the needle in the haystack?
Hepatology (Baltimore, Md.) 2007;46(5):1661-3.
2007: Marianne Antoine; Werner Wirz; Carmen G Tag; Axel M Gressner; Meltem Marvituna; Mathias Wycislo; Claus Hellerbrand; Paul Kiefer
Expression and function of fibroblast growth factor (FGF) 9 in hepatic stellate cells and its role in toxic liver injury.
Biochemical and biophysical research communications 2007;361(2):335-41.
2007: Eray Yagmur; Mohamed Rizk; Sven Stanzel; Claus Hellerbrand; Frank Lammert; Christian Trautwein; Hermann E Wasmuth; Axel M Gressner
Elevation of endoglin (CD105) concentrations in serum of patients with liver cirrhosis and carcinoma.
European journal of gastroenterology & hepatology 2007;19(9):755-61.
2007: Christoph H Osterreicher; Jürgen Schultheiss; Markus Wehler; Nils Homann; Claus Hellerbrand; Beat Künzli; Helmut Friess; Helmut K Seitz; Felix Stickel
Genetic polymorphisms of manganese-superoxide dismutase and glutathione-S-transferase in chronic alcoholic pancreatitis.
Mutagenesis 2007;22(5):305-10.
2007: Frank Tacke; Christian Trautwein; Eray Yagmur; Claus Hellerbrand; Reiner Wiest; David A Brenner; Bernd Schnabl
Up-regulated eotaxin plasma levels in chronic liver disease patients indicate hepatic inflammation, advanced fibrosis and adverse clinical course.
Journal of gastroenterology and hepatology 2007;22(8):1256-64.
2007: Peter Walbrun; Claus Hellerbrand; Thomas S Weiss; Susanne Netter; Daniel Neumaier; Erwin Gaebele; Reiner Wiest; Juergen Schoelmerich; Matthias Froh
Characterization of rat and human Kupffer cells after cryopreservation.
Cryobiology 2007;54(2):164-72.
2007: Claus Hellerbrand; Elisabeth Bumes; Frauke Bataille; Wolfgang Dietmaier; Ramin Massoumi; Anja Bosserhoff
Reduced expression of CYLD in human colon and hepatocellular carcinomas.
Carcinogenesis 2007;28(1):21-7.
2006: Marcus Mühlbauer; Martin Fleck; Christian Schütz; Thomas Weiss; Matthias Froh; Christian Blank; Jürgen Schölmerich; Claus Hellerbrand
PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis.
Journal of hepatology 2006;45(4):520-8.
2006: Markus Neumeier; Claus Hellerbrand; Erwin Gäbele; Roland Buettner; Cornelius Bollheimer; Johanna Weigert; Andreas Schäffler; Thomas S Weiss; Monika Lichtenauer; Jurgen Schölmerich; Christa Buechler
Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosis.
World journal of gastroenterology : WJG 2006;12(34):5490-4.
2006: Guntram Lock; M Dirscherl; Florian Obermeier; Cornelia M Gelbmann; Claus Hellerbrand; Antje Knöll; J Schölmerich; Wolfgang Jilg
Hepatitis C - contamination of toothbrushes: myth or reality?
Journal of viral hepatitis 2006;13(9):571-3.
2006: Marion M Schuierer; Frauke Bataille; Thomas S Weiss; Claus Hellerbrand; Anja Bosserhoff
Raf kinase inhibitor protein is downregulated in hepatocellular carcinoma.
Oncology reports 2006;16(3):451-6.
2006: Nils Homann; Felix Stickel; Inke R König; Arne Jacobs; Klaus Junghanns; Monika Benesova; Detlef Schuppan; Susanne Himsel; Ina Zuber-Jerger; Claus Hellerbrand; Diether Ludwig; Wolfgang H Caselmann; Helmut K Seitz
Alcohol dehydrogenase 1C*1 allele is a genetic marker for alcohol-associated cancer in heavy drinkers.
International journal of cancer. Journal international du cancer 2006;118(8):1998-2002.
2006: Christian E Wrede; Roland Buettner; L Cornelius Bollheimer; Jurgen Schölmerich; Klaus-Dieter Palitzsch; Claus Hellerbrand
Association between serum ferritin and the insulin resistance syndrome in a representative population.
European journal of endocrinology / European Federation of Endocrine Societies 2006;154(2):333-40.
2006: Wolfgang E Thasler; Rania Dayoub; Marcus Mühlbauer; Claus Hellerbrand; Thomas Singer; Anja Gräbe; Karl-Walter Jauch; Hans J Schlitt; Thomas S Weiss
Repression of cytochrome P450 activity in human hepatocytes in vitro by a novel hepatotrophic factor, augmenter of liver regeneration.
The Journal of pharmacology and experimental therapeutics 2006;316(2):822-9.
2006: Claus Hellerbrand; Marcus Mühlbauer; Susanne Wallner; Marion M Schuierer; Iris Behrmann; Frauke Bataille; Thomas Weiss; Jürgen Schölmerich; Anja Bosserhoff
Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma.
Carcinogenesis 2006;27(1):64-72.
2005: C Meiler; M Muhlbauer; Monika Johann; Arndt Hartmann; Bernd Schnabl; Norbert Wodarz; Gerd Schmitz; Jurgen Scholmerich; Claus Hellerbrand
Different effects of a CD14 gene polymorphism on disease outcome in patients with alcoholic liver disease and chronic hepatitis C infection.
World journal of gastroenterology : WJG 2005;11(38):6031-7.
2005: Bernd Schnabl; Kanghong Hu; Marcus Mühlbauer; Claus Hellerbrand; Branko Stefanovic; David A Brenner; Jürgen Schölmerich
Zinc finger protein 267 is up-regulated during the activation process of human hepatic stellate cells and functions as a negative transcriptional regulator of MMP-10.
Biochemical and biophysical research communications 2005;335(1):87-96.
2005: Felix Stickel; Christoph H Osterreicher; Christian Datz; Peter Ferenci; Marco Wölfel; Wolfgang Norgauer; Michael R Kraus; Fritz Wrba; Claus Hellerbrand; Detlef Schuppan
Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis.
Archives of internal medicine 2005;165(16):1835-40.
2005: Sonja Hillebrandt; Hermann E Wasmuth; Ralf Weiskirchen; Claus Hellerbrand; Hildegard Keppeler; Alexa Werth; Ramin Schirin-Sokhan; Gabriele Wilkens; Andreas Geier; Johann Lorenzen; Jörg Köhl; Axel M Gressner; Siegfried Matern; Frank Lammert
Complement factor 5 is a quantitative trait gene that modifies liver fibrogenesis in mice and humans.
Nature genetics 2005;37(8):835-43.
2005: Christoph H Osterreicher; Christian Datz; Felix Stickel; Claus Hellerbrand; Melitta Penz; Harald Hofer; Fritz Wrba; Edward Penner; Detlef Schuppan; Peter Ferenci
TGF-beta1 codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis.
Cytokine 2005;31(2):142-8.
2005: Wolfgang E Thasler; Thilo Schlott; Paul Thelen; Claus Hellerbrand; F Bataille; M Lichtenauer; Hans J Schlitt; Karl-Walter Jauch; Thomas S Weiss
Expression of augmenter of liver regeneration (ALR) in human liver cirrhosis and carcinoma.
Histopathology 2005;47(1):57-66.
2005: Christoph H Osterreicher; Christian Datz; Felix Stickel; Claus Hellerbrand; Melitta Penz; Harald Hofer; Fritz Wrba; Edward Penner; Detlef Schuppan; Peter Ferenci
Association of myeloperoxidase promotor polymorphism with cirrhosis in patients with hereditary hemochromatosis.
Journal of hepatology 2005;42(6):914-9.
2005: Kanghong Hu; Marina Fink; Matthias Froh; Erwin Gäbele; Claus Hellerbrand; Marcus Mühlbauer; Reiner Wiest; Jürgen Schölmerich; Bernd Schnabl
Characterization of the human zinc finger protein 267 promoter: essential role of nuclear factor Y.
Biochimica et biophysica acta 2005;1729(1):14-23.
2005: Marcus Mühlbauer; Susanne Ringel; Arndt Hartmann; Gertrud Lallinger; Thomas S Weiss; Erwin Gäbele; Peter H Wünsch; Jürgen Schölmerich; Claus Hellerbrand
Lack of association between the functional CX3CR1 polymorphism V249I and hepatocellular carcinoma.
Oncology reports 2005;13(5):957-63.
2005: Hao Wang; Senait Mengsteab; Carmen G Tag; Chun-Fang Gao; Claus Hellerbrand; Frank Lammert; Axel M Gressner; Ralf Weiskirchen
Transforming growth factor-beta1 gene polymorphisms are associated with progression of liver fibrosis in Caucasians with chronic hepatitis C infection.
World journal of gastroenterology : WJG 2005;11(13):1929-36.
2005: Claus Hellerbrand; Frauke Bataille; Jacqueline Schlegel; Arndt Hartmann; Marcus Mühlbauer; Jürgen Schölmerich; Reinhard Büttner; Ferdinand Hofstädter; Anja Bosserhoff
In situ expression patterns of melanoma inhibitory activity 2 in healthy and diseased livers.
Liver international : official journal of the International Association for the Study of the Liver 2005;25(2):357-66.
2005: Sigrid Karrer; Anja Bosserhoff; Petra Weiderer; Oliver Distler; Michael Landthaler; Rolf-Markus Szeimies; Ulf Müller-Ladner; Jürgen Schölmerich; Claus Hellerbrand
The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis.
The Journal of investigative dermatology 2005;124(1):92-8.
2005: Frauke Bataille; Gerhard Rogler; Katharina Modes; Ina Poser; Marion M Schuierer; Wolfgang Dietmaier; Petra Ruemmele; Marcus Mühlbauer; Susanne Wallner; Claus Hellerbrand; Anja Bosserhoff
Strong expression of methylthioadenosine phosphorylase (MTAP) in human colon carcinoma cells is regulated by TCF1/[beta]-catenin.
Laboratory investigation; a journal of technical methods and pathology 2005;85(1):124-36.
2004: Marcus Mühlbauer; Thomas S Weiss; Wolfgang E Thasler; Cornelia M Gelbmann; Bernd Schnabl; Jürgen Schölmerich; Claus Hellerbrand
LPS-mediated NFkappaB activation varies between activated human hepatic stellate cells from different donors.
Biochemical and biophysical research communications 2004;325(1):191-7.
2004: Silke Kuphal; Ina Poser; Christian Jobin; Claus Hellerbrand; Anja Bosserhoff
Loss of E-cadherin leads to upregulation of NFkappaB activity in malignant melanoma.
Oncogene 2004;23(52):8509-19.
2004: Heike Steiling; Marcus Mühlbauer; Frauke Bataille; Jürgen Schölmerich; Sabine Werner; Claus Hellerbrand
Activated hepatic stellate cells express keratinocyte growth factor in chronic liver disease.
The American journal of pathology 2004;165(4):1233-41.
2004: Michael Schepke; Gerhard Kleber; Dieter Nürnberg; Jörg Willert; Lydia Koch; Wilfried Veltzke-Schlieker; Claus Hellerbrand; Johannes Kuth; Stefan Schanz; Stefan Kahl; Wolfgang E Fleig; Tilman Sauerbruch
Ligation versus propranolol for the primary prophylaxis of variceal bleeding in cirrhosis.
Hepatology (Baltimore, Md.) 2004;40(1):65-72.
2004: Heiko C Rath; Antje Timmer; Christian Kunkel; Esther Endlicher; Johannes Grossmann; Claus Hellerbrand; Hans Herfarth; Guntram Lock; Ulrike Sahrbacher; Jürgen Schölmerich; Frank Kullmann; Helmut Messmann
Comparison of interobserver agreement for different scoring systems for reflux esophagitis: Impact of level of experience.
Gastrointestinal endoscopy 2004;60(1):44-9.
2004: Marcus Mühlbauer; Brigitte Allard; Anja Bosserhoff; Stephan Kiessling; Hans Herfarth; Gerhard Rogler; Jurgen Schölmerich; Christian Jobin; Claus Hellerbrand
Differential effects of deoxycholic acid and taurodeoxycholic acid on NF-kappa B signal transduction and IL-8 gene expression in colonic epithelial cells.
American journal of physiology. Gastrointestinal and liver physiology 2004;286(6):G1000-8.
2004: Christian E Wrede; Stefanie Hutzler; L Cornelius Bollheimer; Roland Buettner; Claus Hellerbrand; Jürgen Schöelmerich; Klaus-Dieter Palitzsch
Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
The Israel Medical Association journal : IMAJ 2004;6(1):30-3.
2003: Carmen G Tag; Senait Mengsteab; Claus Hellerbrand; Frank Lammert; Axel M Gressner; Ralf Weiskirchen
Analysis of the transforming growth factor-beta1 (TGF-beta1) codon 25 gene polymorphism by LightCycler-analysis in patients with chronic hepatitis C infection.
Cytokine 2003;24(5):173-81.
2003: Marcus Mühlbauer; Anja Bosserhoff; Arndt Hartmann; Wolfgang E Thasler; Thomas S Weiss; Hans Herfarth; Guntram Lock; Jürgen Schölmerich; Claus Hellerbrand
A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease.
Gastroenterology 2003;125(4):1085-93.
2003: Hans Herfarth; Michael Göke; Claus Hellerbrand; Marcus Mühlbauer; Daniela Vogl; Jürgen Schölmerich; Gerhard Rogler
Polymorphism of monocyte chemoattractant protein 1 in Crohn's disease.
International journal of colorectal disease 2003;18(5):401-5.
2003: Claus Hellerbrand; Andreas Pöppl; Arndt Hartmann; Jürgen Schölmerich; Guntram Lock
HFE C282Y heterozygosity in hepatocellular carcinoma: evidence for an increased prevalence.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2003;1(4):279-84.
2003: Anja Bosserhoff; Markus Moser; Juergen Schölmerich; Reinhard Buettner; Claus Hellerbrand
Specific expression and regulation of the new melanoma inhibitory activity-related gene MIA2 in hepatocytes.
The Journal of biological chemistry 2003;278(17):15225-31.
2001: Claus Hellerbrand; Anja Bosserhoff; S Seegers; G Lingner; Christian E Wrede; Guntram Lock; Jurgen Schölmerich; R Büttner
Mutation analysis of the HFE gene in German hemochromatosis patients and controls using automated SSCP-based capillary electrophoresis and a new PCR-ELISA technique.
Scandinavian journal of gastroenterology 2001;36(11):1211-6.
2001: Anja Bosserhoff; Claus Hellerbrand; R Buettner
[Clinical and genetic aspects of hereditary hemochromatosis].
Der Pathologe 2001;22(3):191-6.
2001: Claus Hellerbrand; A Hartmann; G Richter; Antje Knöll; Reiner Wiest; Jürgen Schölmerich; Guntram Lock
Hepatocellular carcinoma in southern Germany: epidemiological and clinicopathological characteristics and risk factors.
Digestive diseases (Basel, Switzerland) 2001;19(4):345-51.
2000: Guntram Lock; Antje Knöll; S Hauer; Cornelia M Gelbmann; Claus Hellerbrand; Wolfgang Jilg; Jurgen Schölmerich; A Hartmann
[Liver histology in hepatitis C: correlation with different biochemical and virological parameters].
Medizinische Klinik (Munich, Germany : 1983) 2000;95(11):603-7.
1999: Anja Bosserhoff; S Seegers; Claus Hellerbrand; Jurgen Schölmerich; R Büttner
Rapid genetic screening for hemochromatosis using automated SSCP-based capillary electrophoresis (SSCP-CE).
BioTechniques 1999;26(6):1106-10.
1999: Branko Stefanovic; Claus Hellerbrand; David A Brenner
Regulatory role of the conserved stem-loop structure at the 5' end of collagen alpha1(I) mRNA.
Molecular and cellular biology 1999;19(6):4334-42.
1999: Claus Hellerbrand; Branko Stefanovic; F Giordano; ER Burchardt; David A Brenner
The role of TGFbeta1 in initiating hepatic stellate cell activation in vivo.
Journal of hepatology 1999;30(1):77-87.
1998: Claus Hellerbrand; Christian Jobin; LL Licato; Ryan Sartor; David A Brenner
Cytokines induce NF-kappaB in activated but not in quiescent rat hepatic stellate cells.
The American journal of physiology 1998;275(2 Pt 1):G269-78.
1998: Christian Jobin; Claus Hellerbrand; LL Licato; David A Brenner; Ryan Sartor
Mediation by NF-kappa B of cytokine induced expression of intercellular adhesion molecule 1 (ICAM-1) in an intestinal epithelial cell line, a process blocked by proteasome inhibitors.
Gut 1998;42(6):779-87.
1998: Claus Hellerbrand; Christian Jobin; Yuji Iimuro; LL Licato; Ryan Sartor; David A Brenner
Inhibition of NFkappaB in activated rat hepatic stellate cells by proteasome inhibitors and an IkappaB super-repressor.
Hepatology (Baltimore, Md.) 1998;27(5):1285-95.
1998: Yuji Iimuro; T Nishiura; Claus Hellerbrand; Kevin E Behrns; Robert Schoonhoven; Joe W Grisham; David A Brenner
NFkappaB prevents apoptosis and liver dysfunction during liver regeneration.
The Journal of clinical investigation 1998;101(4):802-11.
1998: Christian Jobin; Asit Panja; Claus Hellerbrand; Yuji Iimuro; J Didonato; David A Brenner; Ryan Sartor
Inhibition of proinflammatory molecule production by adenovirus-mediated expression of a nuclear factor kappaB super-repressor in human intestinal epithelial cells.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(1):410-8.
1997: Branko Stefanovic; Claus Hellerbrand; Martin Holcik; M Briendl; S Aliebhaber; David A Brenner
Posttranscriptional regulation of collagen alpha1(I) mRNA in hepatic stellate cells.
Molecular and cellular biology 1997;17(9):5201-9.
1995: Branko Stefanovic; Claus Hellerbrand; David A Brenner
Post-transcriptional regulation of collagen alpha 1(I) mRNA in hepatic stellate cells.
Nucleic acids symposium series 1995;(33):212-4.